ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1423
0,00%
Bitcoin
62.856,82
-0,30%
Brent Oil
84,265
0,38%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. NeoGenomics Inc (NEO)

  7. NeoGenomics Inc (NEO) Notícias

NEO

NeoGenomics (NEO)

NeoGenomics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NEO
DataHoraFonteTítuloCódigoCompanhia
30/04/202408:30Business WireNeoGenomics Reports First Quarter 2024 ResultsNASDAQ:NEONeoGenomics Inc
18/04/202408:05Business WireNeoGenomics Announces Senior Leadership PromotionsNASDAQ:NEONeoGenomics Inc
09/04/202408:00Business WireNeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NEONeoGenomics Inc
27/03/202409:30Business WireNeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual MeetingNASDAQ:NEONeoGenomics Inc
20/03/202408:00Business WireNeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) ReportNASDAQ:NEONeoGenomics Inc
06/03/202418:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/03/202419:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NEONeoGenomics Inc
01/03/202409:05Business WireNeoGenomics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:NEONeoGenomics Inc
26/02/202418:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NEONeoGenomics Inc
20/02/202418:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NEONeoGenomics Inc
20/02/202418:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NEONeoGenomics Inc
20/02/202418:05Business WireNeoGenomics Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:NEONeoGenomics Inc
20/02/202407:37IH Market NewsMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil Prices DipNASDAQ:NEONeoGenomics Inc
14/02/202412:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NEONeoGenomics Inc
09/02/202417:17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NEONeoGenomics Inc
01/02/202409:05Business WireNeoGenomics Signs Working with Cancer Pledge in Support of EmployeesNASDAQ:NEONeoGenomics Inc
30/01/202409:05Business WireNeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024NASDAQ:NEONeoGenomics Inc
02/01/202409:05Business WireNeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:NEONeoGenomics Inc
06/11/202318:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NEONeoGenomics Inc
07/07/202319:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
02/06/202319:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEONeoGenomics Inc
01/06/202317:30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NEONeoGenomics Inc
30/05/202317:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NEONeoGenomics Inc
09/05/202317:40Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NEONeoGenomics Inc
07/04/202317:07Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:NEONeoGenomics Inc
07/04/202317:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NEONeoGenomics Inc
07/04/202317:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NEONeoGenomics Inc
22/03/202309:00Business WireMassive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient CareNASDAQ:NEONeoGenomics Inc
24/02/202318:43Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NEONeoGenomics Inc
09/02/202317:43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NEONeoGenomics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NEO

Seu Histórico Recente

BOV
IFCM3
Infracommerce Caxaas ON
BOV
VVEO3
CM Hospitalar ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
TELB4
TELEBRAS PN
BOV
CMIN3
CSN Mineracao S.A ON
BOV
COGN3
COGNA ON
BOV
LUPA3
LUPATECH ON
BOV
PDTC3
Padtec ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
CASH3
Meliuz S.A ON
BOV
RNEW4
RENOVA PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados